By
 In News, WCCT News

WCCT Global announces Edward Kim as Executive Director of Early Clinical Development

 

WCCT Global (WCCTG) is pleased to announce and welcome Mr. Edward Kim as Executive Director, Early Clinical Development. Ed will be overseeing the WCCTG, Cypress and Costa Mesa Clinical Pharmacology Research Units. To make the right calls on which drug candidates to pursue, you need early clinical development insights for more confident decision making and that is exactly what Mr. Edward Kim brings to the table.  Nearly 15 years of his career was with California Clinical Trials/Parexel International, where he served as Director of Clinical Operations. He was responsible for managing all clinical operations (Clinical Research Teams, Pharmacy, Laboratory, and Nursing) for their expanded 100+ beds across their 3 Phase I units. Mr. Kim has conducted over 400 clinical trials supporting CNS indications, Asian ethnobridging, “CSF-dynabridging” programs, and various specialized programs in healthy normal populations. When asked how Ed felt to be joining WCCT Global, he replied, “I am extremely excited to be joining this dynamic and growing organization, and look forward to leveraging my background and knowledge in this space to help WCCTG continue to grow.”

“This is another great addition to WCCT Global,” exclaimed Jon Rojas, WCCTG’s Chief Operating Officer, “because this service offering is part of WCCTG’s core business which continues to grow. Having team members like Mr. Kim is why we are contacted by sponsors all over the world to perform clinical studies in many different therapeutic areas.”

 

Click here to read full press release on the addition of Edward Kim as Executive Director of Early Clinical Development

By MattMiller